Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 2Phase 2 2Phase 1 2

Status

Recruiting 1Completed 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 368Neoplasms 324Neoplasm Metastasis 287Leukemia, Myeloid, Acute 279Breast Neoplasms 275Colorectal Neoplasms 233Melanoma 197Ovarian Neoplasms 189Recurrence 187Multiple Myeloma 177Prostatic Neoplasms 156Pancreatic Neoplasms 156Lung Neoplasms 156Squamous Cell Carcinoma of Head and Neck 148Glioblastoma 145Lymphoma, Non-Hodgkin 143Triple Negative Breast Neoplasms 118Myelodysplastic Syndromes 114Carcinoma, Renal Cell 111Stomach Neoplasms 110Precursor Cell Lymphoblastic Leukemia-Lymphoma 105Glioma 105Advanced Solid Tumors 104Lymphoma 103Lymphoma, Large B-Cell, Diffuse 102Brain Neoplasms 102Lymphoma, B-Cell 98Carcinoma, Hepatocellular 94Endometrial Neoplasms 92Lymphoma, Follicular 90

Interventions

MRX-2843 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Pathologic Processes × 1 year × Clear all
NCT03510104 2026-01-08

Pharmacokinetic and Safety Study of MRX-2843 in Adults With Relapsed/Refractory Advanced and/or Metastatic Solid Tumors

Meryx, Inc.

Phase 1 Completed
42 enrolled

Neoplasm Metastasis, Neoplasms, Neoplastic Processes, Pathologic Processes

NCT07098806 2025-08-01

CA2024-LM-001

Plus Therapeutics

Phase 1 Recruiting
24 enrolled
CNS

Meningeal Neoplasms, Neoplasm Metastasis, Neoplasms, Neoplasms by Site, Nervous System Diseases, Nervous System Neoplasms, Pathologic Processes, Central Nervous System Neoplasms, Meningeal Carcinomatosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡